Macrophagic myofasciitis;La myofasciite a macrophages

Presse Medicale

Volumn 29, Issue 4, 2000, Pages 203-208

  Cherin P ^a   Laforet P ^a   Gherardi R K ^b   Authier, F J ^b   Maisonobe, T ^a   Coquet, M ^c   Mussini, J M ^d   Pellissier, J F ^e   Eymard, B ^a   Herson, S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Grp d'Etud Rech Muscle et le Nerf   (France)

^c HÔPITAL PELLEGRIN   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROMYOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FASCIITIS; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MUSCLE BIOPSY; REVIEW; ADULT; AGED; BIOPSY; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME ASSAY; FEMALE; MALE; MIDDLE AGED; MUSCLE DISEASE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOLOGY; SKELETAL MUSCLE;

CREATINE KINASE;

ADULT; AGED; BIOPSY; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; ENZYME TESTS; FASCIITIS; FEMALE; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PAIN;

EID: 0034606807     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Gherardi R, Coquet M, Chérin P et al. et le GERMMAD : Macrophagic myofasciitis : an emerging entity. Lancet 1998 ; 352347-52.
2. Chérin P, Gherardi RK et le GERMMAD : Apparition d'une nouvelle entité : la myofasciite à macrophages. Rev Rhum 1998 ; 65:593-5.
3. Chérin P, Laforet P, Gherardi R et al. et le GERMMAD : La myofasciite à macrophages : description, hypothèses étiopathogéniques. Rev Méd Interne 1999 ; (sous presse).
4. Chérin P, Caillat-Vigneron N, Gherardi R et al. et le GERMMAD : Intérêt de la scintigraphie au Gallium dans la myofasciite à macrophages. Rev Méd Interne 1998 ; 19(Suppl):408S.
5. Chérin P, Authier JF, Gherardi R, Romero N, Lafore̊t P, Eymard B, Herson S, Caillat-Vigneron N, et le GERMMAD: Interest of Gallium-67 scintigraphy in the diagnosis of a new entity : the macrophagic myofasciitis. Arthritis Rheum (sous presse).
6. Chérin P, Belec L, Gherardi RK, Pennaforte JL. Macrophagic myofasciitis: improvement with an antibiotic therapy. J Rheumatol 1999 ; 26:2286-7.
7. Banker BQ. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong, eds. Myology, 2nd edn, vol 2, New York: McGraw-Hill, 1993 ; pp 1461-86.
8. Chérin P. Recognition and management of myositis. Drugs 1997 ; 54:39-49.
9. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991 ; 325:1487-98.
10. Naschitz JE, Boss JH, Misselevitch I, Yeshurun D, Rosner I. The fasciitis-panniculitis syndromes. Clinical and pathologic features. Medicine 1996 ; 75:6-16.
11. Mayeno AN, Benson LM, Naylor S, Colberg-Beers M, Puchalski JT, Gleich GJ. Biotransformation of 3-(phenylamino) 1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosiniphilia-myalgia syndrome. Chem Res Toxicol 1995; 8:911-16.
12. Hachulla E, Janin A : Les fasciites inflammatoires non infectieuses : un syndrome frontière. Rev Méd Interne 1995 ; 16:325-35.
13. Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ. Myopathy in Whipples's disease. Gut 1977 ; 18:800.
14. Vital Durand D, Lecomte C, Cathébras P, Rousset H, Godeau P. and the SNFMI research group on Whipple disease. Whipple disease: clinical review of 52 cases. Medicine 1997 ; 76:170-84.
15. Misbah SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption: new atypical features. QJ Med 1997 ; 90:765-72.
16. Michelini-Norris MB, Blanchard DK, Pearson CA, Djeu JY. Differential release of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avitulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 1992 ; 165:702-9.
17. Sathe SS, Sarai A, Tsigler D, Nedunchezian D. Pentoxifylline aggravates impairment in tumor recrosis factor-alpha secreation and increases mycobacterial load in macrophages from AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection. J Infect Dis 1994 ; 170:484-7.
18. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-g production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 1996 ; 157:411-16
19. Marth T, Neurath M, Cucchenni BA, Strober W : Defects of monocyte interleukin 12 production and humoral immunity in Whipples's disease. Gastroenterol 1997 ; 113:442-8.
20. Lack EE. Malakoplakia. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of infectious diseases, vol 2, Stamford: Appleton and Lange, 1997 ; pp 1647-54.
21. Dobbins WO III. Whipples's disease. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of infectious diseases, vol 1, Stamford: Appleton and Lange, 1997; pp 897-903.
22. Miranda D, Vuletin JC, Kauffman SL. Disseminated histiocytosis and intestinal malakoplakia. Occurrence due to Mycobacterium intracellulare infection. Arch Pathol Lab Med 1979 ; 103:302-5.
23. Gillin JS, Urmacher C, West R, Shike M. Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology 1983 ; 85:1187-91.
24. Toxic Epidemic Syndrome Study Group. Toxic Epidemic Syndrome. Lancet 1981 ; ii:697-702.
25. Alonzo-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Rocamora-Ripoll A, Beltran-Guttierrez D. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986 ; 15:200-12.
26. Eidson M, Philen RM, Sewell CM, Voorhees R, Kilbourne EM : L-tryptophan and eosinophilia-myalgia syndrome in New Mexico. Lancet 1990 ; 335:645-8.
27. Kaufman LD, Seidman RJ, Gruber BL. L-tryptophan-associated eosinophilic perimyositis, neuritis and fasciitis. A clinicopathologic and laboratory study of 25 patients. Medicine 1990 ; 69:187-99.
28. Waller PA, Clauw D, Cupps T, Metcalf JS, Silver RM, Carwile-Leroy E : Fasciitis not scleroderma following prolonged exposure to an organic solvent (trichloroethylene). J Rheumatol 1994 ; 21:1567-70.
29. Simpson DM, Wolfe DE. Neuronuscular complications of HIV infection and its treatment. AIDS 1991 ; 5:917-26.
30. Gherardi R. Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 1994 ; 20:232-7.
31. Gertner E, Thurn JR, Williams DN, Simpson M, Balfour HH, Rhame F, Henry K. Zidovudine-associated myopathy. Am J Med 1989 ; 86:814-18.
32. Delakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term ziduzidine therapy. N Engl J Med 1990 ; 322:1098-105.
33. Mhiri C, Baudrimont M, Bonne G et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 1991 ; 29:606-14.
34. Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1 alpha) and IL-6 in human monocytes and T-cells. J Rheumatol 1993 ; 20:803-8.
35. Schwartz DA. Emerging and reemerging infections. Progress and challenges in the subspecialty of infectious disease pathology. Arch Pathol Lab Med 1997 ; 121:776-84.